Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
Clinical trial NCT05610488 · UNKNOWN
Trial details
- NCT number
- NCT05610488
- Sponsor
- Vista Klinik
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.